In a report released on December 28, David Larsen from BTIG maintained a Buy rating on Sharecare (SHCR – Research Report), with a price target of $5.00. The company’s shares closed last Friday at $1.08.
Larsen covers the Healthcare sector, focusing on stocks such as LifeMD, Apollo Medical Holdings, and Health Catalyst. According to TipRanks, Larsen has an average return of -6.6% and a 34.68% success rate on recommended stocks.
Sharecare has an analyst consensus of Moderate Buy, with a price target consensus of $3.00.
See Insiders’ Hot Stocks on TipRanks >>
Based on Sharecare’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $113.33 million and a GAAP net loss of $24.45 million. In comparison, last year the company earned a revenue of $114.62 million and had a GAAP net loss of $27.36 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Sharecare (SHCR) Company Description:
Falcon Capital Acquisition Corp is a blank check company.
Read More on SHCR:
